메뉴 건너뛰기




Volumn 33, Issue 10, 2011, Pages 816-823

Evaluation of valproate effects on acylcarnitine in epileptic children by LC-MS/MS

Author keywords

Epileptic children; Fatty acid oxidation; LC MS MS; Valproate; Valproylcarnitine

Indexed keywords

3 HYDROXYISOVALERYLCARNITINE; ACYLCARNITINE; CARBAMAZEPINE; CARNITINE; CLOBAZAM; CLONAZEPAM; DRUG METABOLITE; ETHOSUXIMIDE; PHENOBARBITAL; PHENYTOIN; UNCLASSIFIED DRUG; VALPROIC ACID; VALPROYLCARNITINE; ZONISAMIDE;

EID: 80755163561     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2010.12.003     Document Type: Article
Times cited : (21)

References (28)
  • 1
    • 0036401554 scopus 로고    scopus 로고
    • Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience
    • Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
    • (2002) CNS Drugs , vol.16 , pp. 695-714
    • Perucca, E.1
  • 2
    • 33845653674 scopus 로고    scopus 로고
    • Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003
    • Koenig S.A., Buesing D., Longin E., Oehring R., Haussermann P., Kluger G., et al. Valproic acid-induced hepatopathy: nine new fatalities in Germany from 1994 to 2003. Epilepsia 2006, 47:2027-2031.
    • (2006) Epilepsia , vol.47 , pp. 2027-2031
    • Koenig, S.A.1    Buesing, D.2    Longin, E.3    Oehring, R.4    Haussermann, P.5    Kluger, G.6
  • 4
    • 0022898515 scopus 로고
    • Carnitine status in Reye and Reye-like syndromes
    • Matsuda I., Ohtani Y. Carnitine status in Reye and Reye-like syndromes. Pediatr Neurol 1986, 2:90-94.
    • (1986) Pediatr Neurol , vol.2 , pp. 90-94
    • Matsuda, I.1    Ohtani, Y.2
  • 5
    • 0029075379 scopus 로고
    • Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity
    • Krahenbuhl S., Mang G., Kupferschmidt H., Meier P.J., Krause M. Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity. Gut 1995, 37:140-143.
    • (1995) Gut , vol.37 , pp. 140-143
    • Krahenbuhl, S.1    Mang, G.2    Kupferschmidt, H.3    Meier, P.J.4    Krause, M.5
  • 7
    • 0035933079 scopus 로고    scopus 로고
    • Effect of l-carnitine treatment for valproate-induced hepatotoxicity
    • Bohan T.P., Helton E., McDonald I., Konig S., Gazitt S., Sugimoto T., et al. Effect of l-carnitine treatment for valproate-induced hepatotoxicity. Neurology 2001, 56:1405-1409.
    • (2001) Neurology , vol.56 , pp. 1405-1409
    • Bohan, T.P.1    Helton, E.2    McDonald, I.3    Konig, S.4    Gazitt, S.5    Sugimoto, T.6
  • 8
    • 0019941501 scopus 로고
    • Carnitine deficiency and hyperammonemia associated with valproic acid therapy
    • Ohtani Y., Endo F., Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 1982, 101:782-785.
    • (1982) J Pediatr , vol.101 , pp. 782-785
    • Ohtani, Y.1    Endo, F.2    Matsuda, I.3
  • 9
    • 0022891180 scopus 로고
    • Serum carnitine during valproic acid therapy
    • Laub M.C., Paetzke-Brunner I., Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 1986, 27:559-562.
    • (1986) Epilepsia , vol.27 , pp. 559-562
    • Laub, M.C.1    Paetzke-Brunner, I.2    Jaeger, G.3
  • 11
    • 0033017055 scopus 로고    scopus 로고
    • Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs
    • Verrotti A., Greco R., Morgese G., Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 1999, 29:36-40.
    • (1999) Int J Clin Lab Res , vol.29 , pp. 36-40
    • Verrotti, A.1    Greco, R.2    Morgese, G.3    Chiarelli, F.4
  • 12
    • 0026027090 scopus 로고
    • Carnitine, valproate, and toxicity
    • Coulter D.L. Carnitine, valproate, and toxicity. J Child Neurol 1991, 6:7-14.
    • (1991) J Child Neurol , vol.6 , pp. 7-14
    • Coulter, D.L.1
  • 14
    • 0030575912 scopus 로고    scopus 로고
    • Inhibition of carnitine biosynthesis by valproic acid in rats-the biochemical mechanism of inhibition
    • Farkas V., Bock I., Cseko J., Sandor A. Inhibition of carnitine biosynthesis by valproic acid in rats-the biochemical mechanism of inhibition. Biochem Pharmacol 1996, 52:1429-1433.
    • (1996) Biochem Pharmacol , vol.52 , pp. 1429-1433
    • Farkas, V.1    Bock, I.2    Cseko, J.3    Sandor, A.4
  • 16
    • 27144539588 scopus 로고    scopus 로고
    • Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?
    • Lheureux P.E., Penaloza A., Zahir S., Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?. Crit Care 2005, 9:431-440.
    • (2005) Crit Care , vol.9 , pp. 431-440
    • Lheureux, P.E.1    Penaloza, A.2    Zahir, S.3    Gris, M.4
  • 17
    • 33846235102 scopus 로고    scopus 로고
    • Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS
    • Werner T., Treiss I., Kohlmueller D., Mehlem P., Teich M., Longin E., et al. Effects of valproate on acylcarnitines in children with epilepsy using ESI-MS/MS. Epilepsia 2007, 48:72-76.
    • (2007) Epilepsia , vol.48 , pp. 72-76
    • Werner, T.1    Treiss, I.2    Kohlmueller, D.3    Mehlem, P.4    Teich, M.5    Longin, E.6
  • 18
    • 0035717641 scopus 로고    scopus 로고
    • Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS
    • Silva M.F., Selhorst J., Overmars H., van Gennip A.H., Maya M., Wanders R.J., et al. Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS. Clin Biochem 2001, 34:635-638.
    • (2001) Clin Biochem , vol.34 , pp. 635-638
    • Silva, M.F.1    Selhorst, J.2    Overmars, H.3    van Gennip, A.H.4    Maya, M.5    Wanders, R.J.6
  • 19
    • 33847391557 scopus 로고    scopus 로고
    • Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry
    • Maeda Y., Ito T., Suzuki A., Kurono Y., Ueta A., Yokoi K., et al. Simultaneous quantification of acylcarnitine isomers containing dicarboxylic acylcarnitines in human serum and urine by high-performance liquid chromatography/electrospray ionization-tandem mass spectrometry. Rapid Commun Mass Spectrom 2007, 21:799-806.
    • (2007) Rapid Commun Mass Spectrom , vol.21 , pp. 799-806
    • Maeda, Y.1    Ito, T.2    Suzuki, A.3    Kurono, Y.4    Ueta, A.5    Yokoi, K.6
  • 20
    • 47249124537 scopus 로고    scopus 로고
    • Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency
    • Maeda Y., Ito T., Ohmi H., Yokoi K., Nakajima Y., Ueta A., et al. Determination of 3-hydroxyisovalerylcarnitine and other acylcarnitine levels using liquid chromatography-tandem mass spectrometry in serum and urine of a patient with multiple carboxylase deficiency. J Chromatogr B Analyt Technol Biomed Life Sci 2008, 870:154-159.
    • (2008) J Chromatogr B Analyt Technol Biomed Life Sci , vol.870 , pp. 154-159
    • Maeda, Y.1    Ito, T.2    Ohmi, H.3    Yokoi, K.4    Nakajima, Y.5    Ueta, A.6
  • 21
    • 84886640030 scopus 로고
    • Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry
    • Millington D.S., Bohan T.P., Roe C.R., Yergey A.L., Liberato D.J. Valproylcarnitine: a novel drug metabolite identified by fast atom bombardment and thermospray liquid chromatography-mass spectrometry. Clin Chim Acta 1985, 145:69-76.
    • (1985) Clin Chim Acta , vol.145 , pp. 69-76
    • Millington, D.S.1    Bohan, T.P.2    Roe, C.R.3    Yergey, A.L.4    Liberato, D.J.5
  • 22
    • 0028896016 scopus 로고
    • Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with selected-ion monitoring
    • Muro H., Tatsuhara T., Sugimoto T., Woo M., Nishida N., Murakami K., et al. Determination of urinary valproylcarnitine by gas chromatography-mass spectrometry with selected-ion monitoring. J Chromatogr B Biomed Appl 1995, 663:83-89.
    • (1995) J Chromatogr B Biomed Appl , vol.663 , pp. 83-89
    • Muro, H.1    Tatsuhara, T.2    Sugimoto, T.3    Woo, M.4    Nishida, N.5    Murakami, K.6
  • 24
    • 43149094182 scopus 로고    scopus 로고
    • Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review
    • Silva M.F., Aires C.C., Luis P.B., Ruiter J.P., IJlst L., Duran M., et al. Valproic acid metabolism and its effects on mitochondrial fatty acid oxidation: A review. J Inherit Metab Dis. 2008, 31:205-216.
    • (2008) J Inherit Metab Dis. , vol.31 , pp. 205-216
    • Silva, M.F.1    Aires, C.C.2    Luis, P.B.3    Ruiter, J.P.4    Ijlst, L.5    Duran, M.6
  • 26
    • 0035964970 scopus 로고    scopus 로고
    • Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids
    • Silva M.F., Ruiter J.P., IJlst L., Jakobs C., Duran M., de Almeida I.T., et al. Differential effect of valproate and its Delta2- and Delta4-unsaturated metabolites, on the beta-oxidation rate of long-chain and medium-chain fatty acids. Chem Biol Interact 2001, 137:203-212.
    • (2001) Chem Biol Interact , vol.137 , pp. 203-212
    • Silva, M.F.1    Ruiter, J.P.2    Ijlst, L.3    Jakobs, C.4    Duran, M.5    de Almeida, I.T.6
  • 28
    • 23044515774 scopus 로고    scopus 로고
    • Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy
    • Eyer F., Felgenhauer N., Gempel K., Steimer W., Gerbitz K.D., Zilker T. Acute valproate poisoning: pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy. J Clin Psychopharmacol 2005, 25:376-380.
    • (2005) J Clin Psychopharmacol , vol.25 , pp. 376-380
    • Eyer, F.1    Felgenhauer, N.2    Gempel, K.3    Steimer, W.4    Gerbitz, K.D.5    Zilker, T.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.